I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kowanetz, Marcin
71
results:
english X
Search for persons
X
Format
Online (71)
Mediatypes
Articles (Online) (35)
Bookchapter (Online) (2)
OpenAccess-fulltext (34)
Sorted by: Relevance
Sorted by: Year
?
1
Intratumoral CD103+ CD8+ T cells predict response to PD-L1 ..:
Banchereau, Romain
;
Chitre, Avantika S.
;
Scherl, Alexis
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 4 - p. e002231 , 2021
Link:
https://doi.org/10.1136/..
?
2
C-reactive protein reduction post treatment is associated w..:
Patil, Namrata S.
;
Zou, Wei
;
Mocci, Simonetta
...
PLOS ONE. 16 (2021) 2 - p. e0246486 , 2021
Link:
https://doi.org/10.1371/..
?
3
Clinical Activity and Safety of Atezolizumab in a Phase 1 S..:
Chiang, Anne C.
;
Sequist, Lecia Van Dam
;
Gilbert, Jill
...
Clinical Lung Cancer. 21 (2020) 5 - p. 455-463.e4 , 2020
Link:
https://doi.org/10.1016/..
?
4
Late-differentiated effector neoantigen-specific CD8+ T cel..:
Fehlings, Michael
;
Jhunjhunwala, Suchit
;
Kowanetz, Marcin
...
Journal for ImmunoTherapy of Cancer. 7 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
5
Absence of PD-L1 expression on tumor cells in the context o..:
Theelen, Willemijn S. M. E.
;
Kuilman, Thomas
;
Schulze, Katja
...
PLOS ONE. 14 (2019) 5 - p. e0216864 , 2019
Link:
https://doi.org/10.1371/..
?
6
Immune profiles in primary squamous cell carcinoma of the h..:
Saloura, Vassiliki
;
Izumchenko, Evgeny
;
Zuo, Zhixiang
...
Oral Oncology. 96 (2019) - p. 77-88 , 2019
Link:
https://doi.org/10.1016/..
?
7
Development of a PD-L1 Complementary Diagnostic Immunohisto..:
Vennapusa, Bharathi
;
Baker, Brian
;
Kowanetz, Marcin
...
Applied Immunohistochemistry & Molecular Morphology. 27 (2019) 2 - p. 92-100 , 2019
Link:
https://doi.org/10.1097/..
?
8
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II..:
Spigel, David R.
;
Chaft, Jamie E.
;
Gettinger, Scott
...
Journal of Thoracic Oncology. 13 (2018) 11 - p. 1733-1742 , 2018
Link:
https://doi.org/10.1016/..
?
9
Safety and clinical activity of atezolizumab monotherapy in..:
Horn, Leora
;
Gettinger, Scott N.
;
Gordon, Michael S.
...
European Journal of Cancer. 101 (2018) - p. 201-209 , 2018
Link:
https://doi.org/10.1016/..
?
10
Differential regulation of PD-L1 expression by immune and t..:
Kowanetz, Marcin
;
Zou, Wei
;
Gettinger, Scott N.
...
Proceedings of the National Academy of Sciences of the United States of America. 115 (2018) 43 - p. E10119-E10126 , 2018
Link:
https://www.jstor.org/st..
?
11
Differential regulation of PD-L1 expression by immune and t..:
Kowanetz, Marcin
;
Zou, Wei
;
Gettinger, Scott N.
...
Proceedings of the National Academy of Sciences. 115 (2018) 43 - p. , 2018
Link:
https://doi.org/10.1073/..
?
12
Immune Signaling in Carcinogenesis:
, In:
Predictive Biomarkers in Oncology
,
Yadav, Mahesh
;
Kowanetz, Marcin
;
Koeppen, Hartmut
- p. 327-334 , 2018
Link:
https://doi.org/10.1007/..
?
13
Predictive Biomarkers and Targeted Therapies in Immuno-onco..:
, In:
Predictive Biomarkers in Oncology
,
Koeppen, Hartmut
;
McCleland, Mark L.
;
Kowanetz, Marcin
- p. 335-344 , 2018
Link:
https://doi.org/10.1007/..
?
14
OA03.02 Atezolizumab as 1L Therapy for Advanced NSCLC in PD..:
Garassino, Marina
;
Rizvi, Naiyer
;
Besse, Benjamin
...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S251-S252 , 2017
Link:
https://doi.org/10.1016/..
?
15
Characterization of PD-L1 expression and immune cell infilt..:
Chan, Oscar Siu Hong
;
Kowanetz, Marcin
;
Ng, Wai Tong
...
Oral Oncology. 67 (2017) - p. 52-60 , 2017
Link:
https://doi.org/10.1016/..
1-15